Literature DB >> 16279371

Reversible weight gain and prolactin levels--long-term follow-up in childhood.

F Galluzzi1, R Salti, S Stagi, F La Cauza, F Chiarelli.   

Abstract

In adult patients weight gain is a frequent complaint of hyperprolactinaemia and it has been associated with a high prevalence of obesity. Normalization of prolactin (PRL) levels result in weight loss. The nature of this link is poorly defined. In this report we describe a 14 year-old female with primary amenorrhea and persistent progressive weight gain. The patient's height, weight and BMI were 152 cm, 70 kg, and 30.3 kg/m2, respectively. Basal hormonal investigation showed normal free thyroxin, TSH, IGF-I, cortisol and ACTH values. Serum PRL level was very high (16,278 mIU/l; normal range 63-426 mIU/l). Magnetic resonance imaging scan showed the presence of a pituitary microadenoma. Treatment with the non-selective dopamine agonist pergolide caused a significant reduction of serum PRL concentration with a remarkable decrease of body weight. During follow-up, repeat MRI scan revealed disappearance of the microadenoma. The reduction of the daily dose of pergolide was associated with an increase of serum PRL with significant weight gain. A further reduction of body weight was subsequently observed with an increase of pergolide dosage. Serum PRL measurement may be useful as part of the endocrine work-up of obese children with a history of unexplained recent weight gain, especially if associated with pituitary-gonadal axis dysfunction. The relationship between PRL secretion and weight change needs to be examined in prospective larger studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16279371     DOI: 10.1515/jpem.2005.18.9.921

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  16 in total

1.  Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.

Authors:  C D Gibson; W Karmally; D J McMahon; S L Wardlaw; J Korner
Journal:  Diabetes Obes Metab       Date:  2011-12-27       Impact factor: 6.577

Review 2.  Management of obesity in the elderly: too much and too late?

Authors:  R L Kennedy; U Malabu; M Kazi; V Shahsidhar
Journal:  J Nutr Health Aging       Date:  2008-11       Impact factor: 4.075

3.  Hyperprolactinemia has no effect on plasma ghrelin levels in patients with prolactinoma.

Authors:  Tuncay Delibaşı; Müyesser Sayki Arslan; Erman Çakal; Mustafa Şahin; Oya Topaloğlu; Esra Tutal; İlknur Öztürk Ünsal; Başak Karbek; Bekir Uçan; Aşkın Güngüneş; Melia Karaköse; Mustafa Çalışkan; Taner Demirci; Gülfer Tabur; Mustafa Özbek
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

Review 4.  Prolactin and human weight disturbances: A puzzling and neglected association.

Authors:  Luis G Sobrinho; Nelson D Horseman
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

Review 5.  The effects of hyperprolactinemia on bone and fat.

Authors:  Amal Shibli-Rahhal; Janet Schlechte
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

6.  10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.

Authors:  Lukas Andereggen; Janine Frey; Robert H Andres; Marwan El-Koussy; Jürgen Beck; Rolf W Seiler; Emanuel Christ
Journal:  Endocrine       Date:  2016-09-29       Impact factor: 3.633

Review 7.  The role of prolactin in andrology: what is new?

Authors:  Giulia Rastrelli; Giovanni Corona; Mario Maggi
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

8.  Serum prolactin concentrations in relation to hypopituitarism and obesity in children with optic nerve hypoplasia.

Authors:  Amy M Vedin; Pamela Garcia-Filion; Cassandra Fink; Mark Borchert; Mitchell E Geffner
Journal:  Horm Res Paediatr       Date:  2012-05-10       Impact factor: 2.852

9.  Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.

Authors:  Laura D Ratner; Betina Gonzalez; Petteri Ahtiainen; Noelia P Di Giorgio; Matti Poutanen; Ricardo S Calandra; Ilpo T Huhtaniemi; Susana B Rulli
Journal:  Endocrinology       Date:  2012-11-01       Impact factor: 4.736

10.  Circulating prolactin associates with diabetes and impaired glucose regulation: a population-based study.

Authors:  Tiange Wang; Jieli Lu; Yu Xu; Mian Li; Jichao Sun; Jie Zhang; Baihui Xu; Min Xu; Yuhong Chen; Yufang Bi; Weiqing Wang; Guang Ning
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.